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The amidolytic activities of papain and rat liver cathepsins B, H and L were strongly inhibited by high 
(HMM) and low (LMM) molecular mass kininogens from bovine, human and rat plasmas, and their K, 
values were estimated to be in the order of 10~‘“-lO-~l M for papain and 10~8-10-9 M for cathepsins. The 
derivatives of bovine kininogens, HMM kinin-free protein, HMM kinin- and fragment 1 .2-free protein, 
and LMM kinin-free protein also showed strong inhibitory activity toward these thiol-proteinases. These 
results suggest that a reactive site which interacts with thiol-proteinases is contained in the heavy chain por- 
tion in kininogens. 
Kininogen Thiol-proteinase inhibitor Papain 
1. INTRODUCTION 
Thiol-proteinase inhibitor in human plasma has 
recently been isolated by several investigators and 
its inhibitory activity has been analysed on papain, 
ficin, muscle calpain (CANP) and human liver 
cathepsins B, H and L [l-5]. Recently, Ohkubo et 
al. [6] reported that one of the thiol-proteinase in- 
hibitors (@I-TPI) in human plasma is identical with 
LMM kininogen by analysing the base sequence of 
cDNA for the inhibitor. We purified HMM and 
LMM kininogens from bovine and rat plasmas and 
characterized their chemical properties [7-91. We 
describe here the inhibitory activities of these 
kininogens and human HMM kinin-free protein 
toward papain and cathepsins H, B and L purified 
from rat liver. The inhibitory activities of these 
+ To whom correspondence should be addressed 
Abbreviations: HMM, high molecular mass; LMM, low 
molecular mass 
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kininogens and their derivatives have been com- 
pared in terms of Ki values. The results 
demonstrate a new function of HMM and LMM 
kininogens as thiol-proteinase inhibitor. 
2. MATERIALS AND METHODS 
Bovine HMM and LMM kininogens and their 
derivatives were isolated as in [7,10]. Rat HMM 
kininogen and T-kininogen were purified by the 
methods of Hayashi et al. [8] and Enjyoji et al. [9]. 
Human HMM kinin-free protein was kindly sup- 
plied by Dr K. Fujikawa, Department of 
Biochemistry, University of Washington, Seattle, 
WA. The concentrations of these kininogens and 
their derivatives were calculated from the absor- 
bance at 280 nm and amino acid analysis, as in [7]. 
Cathepsins B [l 11, H [12] and L [13] were purified 
from rat liver as previously reported. Cathepsin B 
was also purified from human liver [l 11. Papain 
was a product of Sigma, St. Louis, MO. The ac- 
tivities of thiol-proteinases were measured using 
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Table 1 
Ki values for the inhibition of various thiol-proteinases by HMM and LMM kininogens and their 
derivatives 
Cathepsin B Cathepsin L Cathepsin H Papain 
Bovine 
HMM kininogen 12 0.7 15 0.07 
HMM kinin-free protein 1.2 0.4 7.8 0.04 
HMM kinin- and fragment 1 .Zfree 
protein 2.0 1.8 12 0.01 
LMM kininogen 23 1.8 44 0.05 
LMM kinin-free protein 11 1.7 9.2 0.02 
Rat 
HMM kininogen 45 1.2 > 2000 0.11 
T-kininogen 170 2.8 470 0.19 
Human 
HMM kinin-free protein 170 0.2 1.9 0.02 
> 2000” 
a For cathepsin 3 purified from human liver 
K, values were calculated by Henderson plot [15] and expressed as nM 
fluorogenic peptide substrates, Z-Phe-Arg-MCA 
for papain, cathepsins B and L, and Arg-MCA for 
cathepsin H in 0.4 M sodium acetate buffer (pH 
5.5), containing 4 mM EDTA and 8 rnM cysteine 
as in [ 141. Ki values were calculated by Henderson 
plot [15]. 
3. RESULTS 
The amidolytic activity of papain was strongly 
inhibited with increasing amounts of HMM and 
LMM kininogens from bovine and rat plasmas. 
The derivatives of bovine kininogens, HMM kinin- 
free protein, HMM kinin- and fragment 1*2-free 
protein and LMM kinin-free protein, and human 
HMM kinin-free protein also inactivated papain, 
whereas S-alkylated heavy chain, fragment 1.2 
and fragment 1’2-light chain derived from bovine 
HMM kininogen did not inhibit significantly (not 
shown). From the slope of inhibition curves with 
the amidase activity vs concentration of kininogens 
and the derivatives, Ki values were calculated by 
Henderson plot, as shown in table 1. The inhibi- 
tion of the amidolytic activity of rat liver cathep- 
sins B, H and L was also analysed in the same way, 
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using kininogens and their derivatives. Bovine 
HMM and LMM kininogens and their derivatives 
and human HMM kinin-free protein inhibited 
cathepsins B, H and L, with Ki values in the order 
of 10-8-10-9 M (table 1). The inhibitory activity 
of rat kininogens on cathepsins B and H, except 
for cathepsin L, was relatively weak, as compared 
with those of bovine kininogens. All these 
kininogens inhibited papain more strongly than 
cathepsins. Although human HMM kinin-free pro- 
tein inhibited rat cathepsins, the inhibitory activity 
on human cathepsin B was very weak. 
4. DISCUSSION 
This paper demonstrates that HMM and LMM 
kininogens from bovine and rat plasmas have a 
strong inhibitory activity on papain and rat liver 
cathepsins B, H and L. Particularly, Ki values for 
the inhibition of papain by these kininogens and 
human HMM kinin-free protein are very low, 
comparable with those of human thiol-proteinase 
inhibitors previously reported [5]. The Ki value of 
rat T-kininogen is also comparable with rat thiol- 
proteinase inhibitor [16]. Ohkubo et al. [6] have 
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described that human HMM kininogen appears to 
lack inhibitory activity toward ficin, although the 
data were not shown. However, the present data 
provide evidence that not only LMM but also 
HMM kininogen has the ability to inhibit thiol- 
proteinases. 
Among the derivatives from bovine kininogens, 
HMM kinin-free protein, HMM kinin- and frag- 
ment 1.2-free protein and LMM kinin-free protein 
show strong inhibitory activity on thiol- 
proteinases. Since the amino acid sequence of the 
heavy chain portions of bovine HMM and LMM 
kininogens are identical [17,18], these results in- 
dicate that a reactive site of the kininogens for 
thiol-proteinase is located in their heavy chain 
portions. 
Although the reason why S-alkylated heavy 
chain prepared from bovine HMM kinin-free pro- 
tein did not show any inhibitory activity remains to 
be established, this may be due to a conforma- 
tional change induced during the reduction and S- 
alkylation procedures. It is of interest that Ki 
values of HMM and LMM kinin-free proteins for 
the inhibition of cathepsins B and H are 
significantly lower than those of kininogens. This 
enhancement of the inhibitory activity of 
kininogens after kinin liberation awaits further 
investigation. 
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